switzerlanden
Is Conservative Equities staging a comeback? Our perspectives on low vol stocks

Is Conservative Equities staging a comeback? Our perspectives on low vol stocks

Product webinar
2020 was a tough year for low-volatility investors, as the rallies in tech and then cyclical value stocks caused defensive equities to lag the market by a wide margin. 2021 looks very different, as the global economy starts to reopen. The Conservative Equities funds are now trading at the largest valuation gap versus the index since their inception in 2006. The strategy’s solid Q1 results suggest that this gap will offer investors a margin of safety for the years to come.
  • Jan Sytze  Mosselaar
    Jan Sytze
    Mosselaar
    Portfolio Manager
  • Pim  van Vliet, PhD
    Pim
    van Vliet, PhD
    Lead Portfolio Manager Conservative Equities

In our latest webinar, portfolio managers Pim van Vliet and Jan Sytze Mosselaar will provide the outlook for the Conservative Equities strategies in 2021 and beyond. They will explain the model and investment philosophy, discuss the differences between cyclical and defensive value stocks, and outline why the prospects for the funds are looking their best since their inception 15 years ago.

At the end of the session, we will have covered:

  • How conservative stocks are well-positioned for the next market rotation
  • The difference between defensive and cyclical value stocks
  • Why the underlying thesis behind the low vol style still holds

The live webinar will take place on Thursday 27 May at 16:00 CET

Logo

Disclaimer Robeco Switzerland Ltd.

The information contained on these pages is for marketing purposes and solely intended for Qualified Investors in accordance with the Swiss Collective Investment Schemes Act of 23 June 2006 (“CISA”) domiciled in Switzerland, Professional Clients in accordance with Annex II of the Markets in Financial Instruments Directive II (“MiFID II”) domiciled in the European Union und European Economic Area with a license to distribute / promote financial instruments in such capacity or herewith requesting respective information on products and services in their capacity as Professional Clients. 

The Funds are domiciled in Luxembourg and The Netherlands. ACOLIN Fund Services AG, postal address: Affolternstrasse 56, 8050 Zürich, acts as the Swiss representative of the Fund(s). UBS Switzerland AG, Bahnhofstrasse 45, 8001 Zurich, postal address: Europastrasse 2, P.O. Box, CH-8152 Opfikon, acts as the Swiss paying agent. The prospectus, the Key Investor Information Documents (KIIDs), the articles of association, the annual and semi-annual reports of the Fund(s) may be obtained, on simple request and free of charge, at the office of the Swiss representative ACOLIN Fund Services AG. The prospectuses are also available via the website www.robeco.ch. Some funds about which information is shown on these pages may fall outside the scope of the Swiss Collective Investment Schemes Act of 26 June 2006 (“CISA”) and therefore do not (need to) have a license from or registration with the Swiss Financial Market Supervisory Authority (FINMA). 

Some funds about which information is shown on this website may not be available in your domicile country. Please check the registration status in your respective domicile country. To view the RobecoSwitzerland Ltd. products that are registered/available in your country, please go to the respective Fund Selector, which can be found on this website and select your country of domicile. 

Neither information nor any opinion expressed on this website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco Switzerland Ltd. product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports. 

By clicking “I agree” you confirm that you/the company you represent falls under one of the above-mentioned categories of addressees and that you have read, understood and accept the terms of use for this website.

I Disagree